These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21547001)

  • 1. Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis.
    Lu C; Mishra A; Zhu YJ; Meltzer P; Cheng SY
    Am J Cancer Res; 2011; 1(2):168-191. PubMed ID: 21547001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma.
    Lu C; Mishra A; Zhu YJ; Meltzer P; Cheng SY
    Am J Cancer Res; 2011 Jan; 1(1):1-13. PubMed ID: 21562609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.
    Lu C; Zhu X; Willingham MC; Cheng SY
    Oncogene; 2012 Apr; 31(16):2007-16. PubMed ID: 21909131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis.
    Lu C; Cheng SY
    Steroids; 2011 Aug; 76(9):885-91. PubMed ID: 21473875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor.
    Zhao L; Zhu X; Won Park J; Fozzatti L; Willingham M; Cheng SY
    Endocrinology; 2012 Oct; 153(10):5090-100. PubMed ID: 22919057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone receptors and cancer.
    Kim WG; Cheng SY
    Biochim Biophys Acta; 2013 Jul; 1830(7):3928-36. PubMed ID: 22507269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of integrin-ERBB2 signaling in undifferentiated thyroid cancer.
    Zhu X; Zhu YJ; Kim DW; Meltzer P; Cheng SY
    Am J Cancer Res; 2014; 4(6):776-88. PubMed ID: 25520867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation suppression prevents tumor cell proliferation in a mouse model of thyroid cancer.
    Park S; Kim M; Zhu J; Lee WK; Altan-Bonnet G; Meltzer P; Cheng SY
    Am J Cancer Res; 2020; 10(6):1857-1870. PubMed ID: 32642296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.
    Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY
    PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
    Zhu X; Kim DW; Zhao L; Willingham MC; Cheng SY
    Endocr Relat Cancer; 2016 Jul; 23(7):521-33. PubMed ID: 27267120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer.
    Kim CS; Furuya F; Ying H; Kato Y; Hanover JA; Cheng SY
    Endocrinology; 2007 Mar; 148(3):1306-12. PubMed ID: 17170101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into regulation of lipid metabolism by thyroid hormone.
    Zhu X; Cheng SY
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):408-13. PubMed ID: 20644471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model.
    Park S; Zhu J; Altan-Bonnet G; Cheng SY
    Am J Cancer Res; 2019; 9(7):1439-1453. PubMed ID: 31392080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.
    Guigon CJ; Kim DW; Willingham MC; Cheng SY
    Oncogene; 2011 Jul; 30(30):3381-90. PubMed ID: 21399657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional telomere dynamics in follicular thyroid cancer.
    Wark L; Danescu A; Natarajan S; Zhu X; Cheng SY; Hombach-Klonisch S; Mai S; Klonisch T
    Thyroid; 2014 Feb; 24(2):296-304. PubMed ID: 23819464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis.
    Guigon CJ; Cheng SY
    Mol Cell Endocrinol; 2009 Sep; 308(1-2):63-9. PubMed ID: 19549593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression.
    Kim WG; Zhu X; Kim DW; Zhang L; Kebebew E; Cheng SY
    Endocrinology; 2013 Jan; 154(1):25-35. PubMed ID: 23183175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
    Kim WG; Zhao L; Kim DW; Willingham MC; Cheng SY
    Thyroid; 2014 Feb; 24(2):260-9. PubMed ID: 23731250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors.
    Furuya F; Lu C; Guigon CJ; Cheng SY
    Steroids; 2009 Jul; 74(7):628-34. PubMed ID: 19014961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.